Patents by Inventor Miyuki Katou

Miyuki Katou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7374923
    Abstract: A screening tool and a screening method for a therapeutic agent for type II diabetes, particularly an agent for alleviating insulin resistance are disclosed. A novel polypeptide, a polynucleotide, a vector, a promoter, and a transformant which are useful in the screening tool and the screening method, are also disclosed.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: May 20, 2008
    Assignee: Astellas Pharma Inc.
    Inventors: Kunitake Abe, Masayoshi Takeda, Noboru Yamaji, Miyuki Katou, Tetsuo Matsui
  • Publication number: 20070077591
    Abstract: A screening tool and a screening method for a therapeutic agent for type II diabetes, particularly an agent for alleviating insulin resistance are disclosed. A novel polypeptide, a polynucleotide, a vector, a promoter, and a transformant which are useful in the screening tool and the screening method, are also disclosed.
    Type: Application
    Filed: November 7, 2006
    Publication date: April 5, 2007
    Inventors: Kunitake Abe, Masayoshi Takeda, Noboru Yamaji, Miyuki Katou, Tetsuo Matsui
  • Patent number: 7157567
    Abstract: A screening tool and a screening method for a therapeutic agent for type II diabetes, particularly an agent for alleviating insulin resistance are disclosed. A novel polypeptide, a polynucleotide, a vector, a promoter, and a transformant which are useful in the screening tool and the screening method, are also disclosed.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: January 2, 2007
    Assignee: Astellas Pharma, Inc.
    Inventors: Kunitake Abe, Noboru Yamaji, Miyuki Katou, Tetsuo Matsui
  • Publication number: 20040241778
    Abstract: A screening tool and a screening method for a therapeutic agent for type II diabetes, particularly an agent for alleviating insulin resistance are disclosed. A novel polypeptide, a polynucleotide, a vector, a promoter, and a transformant which are useful in the screening tool and the screening method, are also disclosed.
    Type: Application
    Filed: March 31, 2004
    Publication date: December 2, 2004
    Inventors: Kunitake Abe, Masayoshi Takeda, Noboru Yamaji, Miyuki Katou, Tetsuo Matsui